Newborn Head Molding and Later Asymmetries

November 27, 2023 updated by: Marita Valkama, University of Oulu

Newborn Head Molding and Later Asymmetries in Follow up (3D Head Shape Modelling)

Prospective randomized clinical interventional trial after birth in maternity ward, and follow up to 8-9 years of age.

Hypothesis: Preventive handling and caring advices to parents of newborns decrease craniofacial asymmetries (deformational plagiocephaly and torticollis). The minimum sample size of the study was calculated at 86 (43 in each arm) using a 5% significance level, a power of 80% and a fall in the prevalence of DP from 31% to 8%. Craniofacial asymmetries and appearances of occlusal defects are followed up to 9 years. 50 preterm infants can participate without intervention.

Study Overview

Detailed Description

The amount of craniofacial abnormal molding after birth in newborns and the frequency of plagiocephaly in infancy or later consequences of those in childhood are not known in finnish population. Head malposition and deformational plagiocephaly, however, have been linked to delayed development in early life and even much later to orthognathic problems demanding surgery in adulthood.

In this study parents with healthy newborns are randomized to have normal discharge home or discharged with extra advice information for caregivers; to charge both sided feeding and handling habits; to change regularly sleeping and lying positions; to have early tummy times.

Anthropometric measurements of the infants; tilting degrees of the head and rotations of the neck (range of movement =ROM) are taken at discharge home and at the age of 3 and 6 months, and 1, 3, 5-6 and 8-9 years. Two-dimensional digital photographs (upto the age of 6 months) and three-dimensional imaging (from the age of 3 months) are taken to measurements of the head shape (Cephalic index=CI and (approximate) Oblique Cranial Length Ratio= (a)OCLR measured using a semiautomated, computer-based method). The development quotient by Griffiths scales are assessed at the age of 3 and 6 months. Dental occlusal defect evaluation are started at the age of 3 ys.

Study Type

Interventional

Enrollment (Estimated)

135

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oulu, Finland, 90220
        • Oulu University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 6 days (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 1-6 days after birth;
  • Healthy newborns in maternal ward, and living in near by Oulu region.
  • Preterms at the age of 34-44 gestation weeks in near by Oulu region (non randomized)

Exclusion Criteria:

  • Congenital anomalies,
  • Very early discharge,
  • Parental refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active
Newborns with preventive caring advices
Advices to prevent head molding
Placebo Comparator: Surveillance
Newborns with normal caring advices
Normal handling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of Plagiocephaly (The number of children in groups with plagiocephaly (CI, OCLR =/> 104% )
Time Frame: 3 months
The number of children in groups with plagiocephaly (CI, OCLR =/> 104%)
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity of plagiocephaly
Time Frame: 3 months
The number of children in groups with plagiocephaly as mild; aOCLR 104-107%; moderate 107-111%; severe =/>111 %
3 months
Change in plagiocephaly
Time Frame: From 3 to 6 months
The number of children in groups with plagiocephaly as mild; aOCLR 104-107%; moderate 107-111%; severe =/>111 %
From 3 to 6 months
Occlusal defects
Time Frame: 6 years
The number of children in groups with occlusal defects
6 years
Change in occlusal defects
Time Frame: from 6 years to 10 years
The number of children with occlusal defects
from 6 years to 10 years
Change in facial symmetry
Time Frame: from 6 years to 10 years
The number of children with facial asymmetry
from 6 years to 10 years
Change in occlusal defects
Time Frame: from 10 years to 15 years
The number of children with occlusal defects
from 10 years to 15 years
Change in facial symmetry
Time Frame: from 10 years to 15 years
The number of children with facial asymmetry
from 10 years to 15 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Development (Development quotients by Griffiths scales in groups)
Time Frame: 3 months
Difference in Development quotients by Griffiths scales in groups
3 months
Change in Development (Development quotients by Griffiths scales in groups)
Time Frame: From 3 months to 6 months
Difference in Development quotients by Griffiths scales in groups
From 3 months to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Pertti Pirttiniemi, Professor, University of Oulu
  • Principal Investigator: Marita Valkama, Ph.D., M.D., University of Oulu, Oulu University Hospital
  • Study Director: Virpi Harila, Ph.D., University of Oulu
  • Principal Investigator: Henri Aarnivala, M.D., University of Oulu
  • Principal Investigator: Tuomo Heikkinen, Dos, University of Oulu
  • Principal Investigator: Ville Vuollo, Ph.M., University of Oulu

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2012

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

October 28, 2014

First Submitted That Met QC Criteria

November 2, 2014

First Posted (Estimated)

November 5, 2014

Study Record Updates

Last Update Posted (Actual)

November 28, 2023

Last Update Submitted That Met QC Criteria

November 27, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Plagiocephaly

Clinical Trials on Newborns with preventive caring advices

3
Subscribe